29.03.2012 • NewsCatalisti4-Butanediolbio-based

BioAmber Produces Bio-based 1,4-Butanediol

BioAmber has scaled up its hydrogenation catalyst technology under license from DuPont and converted multi-ton quantities of bio-succinic acid into 100% bio-based 1,4-butanediol (1,4-BDO), tetrahydrofuran (THF) and gamma-butyrolactone (GBL).

BioAmber believes the global addressable market for these products exceeds $4 billion, and that they are principally used to make polyesters, polyurethanes, spandex and biodegradable plastics.

Using bio-succinic acid made at its French facility as a starting material, BioAmber successfully completed a 1,4-BDO production campaign in collaboration with one of the world's leading commercial catalyst suppliers and a toll manufacturer possessing large-scale hydrogenation reactors and distillation columns.

"This is the culmination of two years of work and an important milestone in the development of our bio-based 1,4-BDO platform. We have been able to couple the DuPont catalyst technology with our bio-succinic acid production to manufacture high purity bio-based 1,4-BDO at demonstration scale," Jim Millis, BioAmber's Chief Technology Officer said. "We are developing an integrated plant engineering design that combines the production of bio-succinic acid and bio-based 1,4-BDO on a single site," he added.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

most read

Photo
22.04.2025 • News

BASF Divests Two Joint Ventures in China

BASF has divested its shares in the joint venture companies, BASF Markor Chemical Manufacturing (Xinjiang) Co., Ltd. and Markor Meiou Chemical (Xinjiang) Co., Ltd. in Korla, China, to Verde Chemical Singapore Pte. Ltd.

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.